Can you provide the last earnings date for CLOVIS ONCOLOGY INC?
CLOVIS ONCOLOGY INC (CLVS) last reported earnings on 11/9/2022.
CLOVIS ONCOLOGY INC (CLVS) Earnings History & Surprises
NASDAQ:CLVS • US1894641000
Current stock price
0.0812 USD
0 (-5.58%)
At close:
0.078 USD
0 (-3.94%)
After Hours:
CLVS Earnings overview
Past quarterly earnings results for CLOVIS ONCOLOGY INC (CLVS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Feb 21, 2023
- Period
- Q4 / 2022
- EPS Estimate
- -$0.32
- Revenue Estimate
- 32.17M
Last Reported
Most Recent- Release Date
- Nov 9, 2022
- Period
- Q3 / 2022
- EPS Reported
- -$0.39
- EPS Surprise
- 7.49%
- Revenue Surprise
- -9.51%
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2022 | -0.39 | -0.42 | 7.49% | 30.36% | 30.663M | 33.885M | -9.51% | -19.13% |
| Q2 2022 | -0.50 | -0.42 | -18.60% | 18.03% | 32.143M | 37.771M | -14.90% | -12.70% |
| Q1 2022 | -0.44 | -0.44 | 0.26% | 31.25% | 34.247M | 37.715M | -9.20% | -9.99% |
| Q4 2021 | -0.48 | -0.58 | 17.44% | 52.94% | 35.968M | 38.406M | -6.35% | -16.93% |
| Q3 2021 | -0.56 | -0.49 | -14.86% | 37.08% | 37.916M | 40.238M | -5.77% | -2.20% |
| Q2 2021 | -0.61 | -0.58 | -5.85% | 46.96% | 36.82M | 42.164M | -12.67% | -7.70% |
| Q1 2021 | -0.64 | -0.73 | 12.65% | 50.00% | 38.05M | 45.437M | -16.26% | -10.60% |
| Q4 2020 | -1.02 | -0.79 | -29.87% | - | 43.3M | 44.081M | -1.77% | - |
| Q3 2020 | -0.89 | -1.01 | 12.01% | - | 38.77M | 43.494M | -10.86% | - |
| Q2 2020 | -1.15 | -1.07 | -7.95% | - | 39.89M | 45.541M | -12.41% | - |
| Q1 2020 | -1.28 | -1.30 | 1.88% | - | 42.56M | 42.067M | 1.17% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
1.65%
Max EPS beat (4)
17.44%
Min EPS beat (4)
-18.60%
Revenue beat statistics
Revenue beat (4)
0
Average Revenue beat (4)
-9.99%
Max Revenue beat (4)
-6.35%
Min Revenue beat (4)
-14.90%
Analysis
In the last 4 quarters, CLVS has beaten EPS estimates in 3 out of 4 releases
CLVS has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, CLVS has beaten the EPS estimates by 1.6% on average.
In the last 4 quarters, CLVS reported -10.0% below the revenue estimates on average.
Related analysis
CLOVIS ONCOLOGY INC / CLVS Earnings FAQ
Did CLOVIS ONCOLOGY INC (CLVS) beat earnings estimates last quarter?
CLOVIS ONCOLOGY INC (CLVS) beat EPS estimates and missed revenue estimates in the most recent quarter.
How often does CLOVIS ONCOLOGY INC (CLVS) beat earnings estimates?
In the last 4 quarters, CLOVIS ONCOLOGY INC (CLVS) has beaten EPS estimates in 3 out of 4 releases.